Andrew Booth Selected Research

Andrew Booth Research Topics

8	Dementia (Dementias) 01/2021 - 10/2014
6	Cognitive Dysfunction 01/2020 - 10/2014
2	Chronic Pain 01/2022 - 10/2020
2	Pain (Aches) 01/2022 - 01/2020
2	Intermittent Claudication 01/2015 - 01/2012
1	Type 2 Diabetes Mellitus (MODY) 02/2022
1	Noncommunicable Diseases 01/2021
1	Obesity 01/2020
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2020
1	Fatigue 01/2020
1	Alzheimer Disease (Alzheimer's Disease) 01/2019
1	Genetic Risk Score 01/2019
1	Leukemia 01/2019
1	Neoplasms (Cancer) 01/2019
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2019
1	Dizziness (Lightheadedness) 01/2018
1	Orthostatic Hypotension (Postural Hypotension) 01/2018
1	Isolated Systolic Hypertension 07/2015
1	Nausea 01/2015
1	Hypertension (High Blood Pressure) 10/2014
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2014
1	Tuberculosis (Tuberculoses) 01/2014
1	Peripheral Arterial Occlusive Disease 1 01/2012
1	Breast Neoplasms (Breast Cancer) 09/2008

2	Analgesics (Analgesic Drugs)IBA 01/2022 - 10/2020
2	Antihypertensive Agents (Antihypertensives)IBA 01/2020 - 10/2014
2	Pain-FreeIBA 01/2015 - 01/2012
2	Pentoxifylline (Trental)FDA LinkGeneric 01/2015 - 01/2012
1	Particulate MatterIBA 01/2021
1	CholesterolIBA 01/2020
1	DiureticsIBA 01/2020
1	ApolipoproteinsIBA 01/2019
1	Apolipoproteins E (ApoE)IBA 01/2019
1	Biological ProductsIBA 01/2019
1	Pharmaceutical PreparationsIBA 01/2019
1	Environmental Pollutants (Pollutants, Environmental)IBA 01/2019
1	Liposomes (Liposome)IBA 01/2019
1	Air Pollutants (Pollutants, Air)IBA 01/2019
1	IronIBA 01/2018
1	hydroxide ionIBA 01/2018
1	CilazaprilIBA 07/2015
1	NitrendipineIBA 07/2015
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 10/2014
1	Isoniazid (Ftivazide)FDA LinkGeneric 01/2014
1	Oxygen (Dioxygen)IBA 01/2012
1	Paclitaxel (Taxol)FDA LinkGeneric 09/2008
1	Docetaxel (Taxotere)FDA Link 09/2008

3	Therapeutics 01/2020 - 01/2014
2	Neurofeedback 01/2022 - 10/2020
1	Glycemic Control 02/2022
1	Personal Protective Equipment 01/2020
1	Secondary Prevention 01/2012